PamGene Gets $2.7M in Dutch Grants, Collaborates on Two Studies
Mar 09, 2005
NEW YORK, March 9 (GenomeWeb News) - PamGene, a Dutch DNA chip provider, has secured €2 million ($2.7) million in grant money from the Dutch government, the company said today.
The funding was made available through SenterNovem, a government agency. PamGene said it will use the cash to help it develop systems biology and bioinformatics applications on its PamGene array platform.
The company also revealed that it is a participant in the European Union's 6th Framework Programme through an approved project that seeks to develop a rapid molecular diagnostic for mitochondrial diseases. Partners include the Netherlands Proteomics Centre, the University of Maastricht, and others.
PamGene will also be collaborating with the Netherlands Proteomics Centre to improve protemics research tools and to aid its mission of achieving functional proteomics capabilities.
In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.